image
Tempest Therapeutics, Inc. TPST
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.42
-3.05 %
$ 23.5 M
Market Cap
-0.34
P/E
BALANCE SHEET
41.5 M ASSETS
-19.60%
Growth Rates
1Year -19.60%
3Years -17.26%
5Years -11.16%
7Years 11.14%
10Years -4.47%
22.4 M LIABILITIES
-9.96%
Growth Rates
1Year -9.96%
3Years -15.54%
5Years 8.17%
7Years 24.48%
10Years 8.12%
19.1 M EQUITY
-28.55%
Growth Rates
1Year -28.55%
3Years -19.10%
5Years -20.05%
7Years 35.95%
10Years -10.08%
BALANCE SHEET DECOMPOSITION
Balance Sheet Tempest Therapeutics, Inc.
image
Current Assets 31.5 M
Cash & Short-Term Investments 30.3 M
Receivables 0
Other Current Assets 1.21 M
Non-Current Assets 10 M
Long-Term Investments 0
PP&E 9.53 M
Other Non-Current Assets 485 K
72.96 %2.91 %22.97 %Total Assets$41.5m
Current Liabilities 14.2 M
Accounts Payable 2.45 M
Short-Term Debt 7.22 M
Other Current Liabilities 4.55 M
Non-Current Liabilities 8.14 M
Long-Term Debt 0
Other Non-Current Liabilities 8.14 M
10.96 %32.30 %20.33 %36.41 %Total Liabilities$22.4m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 30.3 39.2 31.2 51.8 18.8 63.5 73.3 17.6 43.9 43.4 6.4 18.1 14.8 4.5
Short Term Investments 0 0 0 0 0 0 4.4 51.5 70.5 83.4 53.8 26.3 16.6 0
Receivables 0 0 0 0 0.3 1.3 2.3 1.0 0 0 0 0 0 0
Inventory 0 0 0 1.6 0.7 0 0 1 0 0 0 0 0 0
Other Current Assets 0.5 1.1 1.4 17.1 0.7 8.7 3.4 (48.5) 2.1 3.0 1.6 0.7 0.6 44 K
Total Current Assets 31.5 40.4 33.0 69.0 19.8 71.1 83.4 19.7 116.4 129.9 61.9 45.1 32.0 4.6
PP&E 9.5 10.8 12.7 4.2 3.0 3.3 0 3.1 5.6 8.3 3.4 0.9 0.8 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0.4 0.1 0.5 0.4 0 1.5 0 0
Other Long Term Assets 0.5 0.4 0.4 0.1 51 K 0.5 0.2 (3.2) 23 K 0 0.3 88 K 93 K 0
Other Assets 0 0 0 0 0 1 0 0 0 1 0 0 0 0
Total Assets 41.5 51.6 46.1 73.2 22.9 75.0 84.1 19.8 122.5 138.6 65.6 47.5 32.8 4.6
LIABILITIES
Accounts Payable 2.5 0.8 1.1 1.0 1.1 1.5 2.0 1.3 2.2 3.4 2.5 1.7 0.9 0.3
Short Term Debt 7.2 5.2 2.8 2.9 0.7 2.0 0.2 0.2 0 0 0 0 0 0
Other Current Liabilities 4.5 3.3 3.3 16.2 1.4 9.0 7.6 2.3 11.0 7.9 7.7 4.1 1.2 0.4
Total Current Liabilities 14.2 9.4 7.3 20.0 3.2 12.5 9.8 4.1 13.2 11.2 10.2 5.8 2.1 0.7
Long Term Debt 0 15.4 20.7 17.1 1.7 2.3 0.4 0.6 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 86.7 0.2 0.8 0.1 1.1 0.5 73 K 70 K 7 K 87 K
Total Liabilities 22.4 24.8 28.0 37.1 91.7 15.1 11.0 4.8 14.3 11.8 10.2 5.8 2.1 0.8
EQUITY
Common Stock 44 K 22 K 11 K 7 K 15 K 18 K 13 K 36 K 36 K 27 K 24 K 18 K 14 K 2 K
Retained Earnings (207.1) (165.3) (135.8) (100.1) (71.8) (208.7) (164.1) (136.9) (250.2) (167.9) (94.7) (45.2) (16.1) (2.6)
Other Accumulative Comprehensive Income/Loss 0 0 0 (73.2) 0.5 0.2 0.1 19 K 60 K (0.2) (1.1) (0.7) 6 K 0
Total Equity 19.1 26.8 18.1 36.1 (68.1) 59.9 73.1 15.0 108.2 126.8 55.3 41.7 30.7 3.8
Total Liabilities and Equity 41.5 51.6 46.1 73.2 22.9 75.0 84.1 19.8 122.5 138.6 65.6 47.5 32.8 4.6
SHARES OUTSTANDING
Common Shares Outstanding 27.9 15.4 11.5 3.8 31.2 K 0.9 0.1 1.17 K 0.1 0.1 0.1 0.1 0 0